Oncimmune Holdings (GB:ONC) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Oncimmune Holdings, a leader in autoantibody profiling for precision medicine, has distributed a Circular to its shareholders outlining details of its upcoming General Meeting. This meeting, scheduled for November 8, 2024, is set to address resolutions for Fundraising and Debt Restructuring. The company’s initiative aims to bolster its financial health and enhance its collaborations in the pharmaceutical and biotech sectors.
For further insights into GB:ONC stock, check out TipRanks’ Stock Analysis page.
